Skip to main content

Table 2 Evaluation of the prognostic significance of SR-BI staining intensity

From: The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence

Variable

P-value

Risk ratio

95 % Confidence interval

Cancer vs. non-cancer

<0.0001

2.128

1.693–2.675

GS ≥ 7 vs. GS ≤ 6

<0.0001

2.907

1.673–5.050

pT3/pT4 vs. pT2

0.371

1.269

0.739–2.182

Met. pos. vs. met. neg.

0.207

1.351

0.837–2.182